<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of Clinical and Experimental Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Annals of Clinical and Experimental Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Анналы клинической и экспериментальной неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-5473</issn><issn publication-format="electronic">2409-2533</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">474</article-id><article-id pub-id-type="doi">10.17816/ACEN.2017.2.5</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Assessment of the effects of cellular therapy on reproduction of the conditioned passive avoidance reflex in rats with quinoline-induced model of Huntington’s disease</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка эффектов клеточной терапии на воспроизведение условного рефлекса пассивного избегания у крыс с хинолин-индуцированной моделью болезни Гентингтона</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stavrovskaya</surname><given-names>Alla V.</given-names></name><name xml:lang="ru"><surname>Ставровская</surname><given-names>Алла Вадимовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Novosadova</surname><given-names>Ekaterina V.</given-names></name><name xml:lang="ru"><surname>Новосадова</surname><given-names>Екатерина В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yamshchikova</surname><given-names>Nina G.</given-names></name><name xml:lang="ru"><surname>Ямщикова</surname><given-names>Нина Гавриловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Olshansky</surname><given-names>Artem S.</given-names></name><name xml:lang="ru"><surname>Ольшанский</surname><given-names>Артем Сергеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gushchina</surname><given-names>Anastasiya S.</given-names></name><name xml:lang="ru"><surname>Гущина</surname><given-names>Анастасия Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Konovalova</surname><given-names>Eugeniya V.</given-names></name><name xml:lang="ru"><surname>Коновалова</surname><given-names>Евгения В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Grivennikov</surname><given-names>Igor' A.</given-names></name><name xml:lang="ru"><surname>Гривенников</surname><given-names>Игорь А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2704-6282</contrib-id><name-alternatives><name xml:lang="en"><surname>Illarioshkin</surname><given-names>Sergey N.</given-names></name><name xml:lang="ru"><surname>Иллариошкин</surname><given-names>Сергей Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Prof., Corr. Member of the Russian Academy of Sciences, Deputy Director, Head, Department for brain research</p></bio><bio xml:lang="ru"><p>д.м.н., проф., член-корр. РАН, зам. директора по научной работе, рук. отдела исследований мозга</p></bio><email>alla_stav@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр неврологии»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Molecular Genetics of RAS</institution></aff><aff><institution xml:lang="ru">ФГБУН «Институт молекулярной генетики» РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-08-06" publication-format="electronic"><day>06</day><month>08</month><year>2017</year></pub-date><volume>11</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>36</fpage><lpage>41</lpage><history><date date-type="received" iso-8601-date="2017-08-06"><day>06</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Stavrovskaya A.V., Novosadova E.V., Yamshchikova N.G., Ol’shansky A.S., Gushchina A.S., Konovalova E.V., Grivennikov I.A., Illarioshkin S.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Stavrovskaya A.V., Novosadova E.V., Yamshchikova N.G., Ol’shansky A.S., Gushchina A.S., Konovalova E.V., Grivennikov I.A., Illarioshkin S.N.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Stavrovskaya A.V., Novosadova E.V., Yamshchikova N.G., Ol’shansky A.S., Gushchina A.S., Konovalova E.V., Grivennikov I.A., Illarioshkin S.N.</copyright-holder><copyright-holder xml:lang="ru">Stavrovskaya A.V., Novosadova E.V., Yamshchikova N.G., Ol’shansky A.S., Gushchina A.S., Konovalova E.V., Grivennikov I.A., Illarioshkin S.N.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://annaly-nevrologii.com/pathID/article/view/474">https://annaly-nevrologii.com/pathID/article/view/474</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> The model involving injection of quinolinic acid (QA) into the rat striatum simulates many clinical and morphological characteristics of Huntington’s disease (HD). Searching for effective treatment methods is rather topical because of the fatality of HD. One of such methods is to create a neuroprotective environment to slow down the current degenerative process and/or replace dead neurons. In particular, this can be performed by transplantation of cells capable of undergoing neuronal differentiation and integration into the proper structural and functional brain networks.</p> <p><bold>Objective</bold>. To assess effectiveness and safety of transplantation of neural progenitors differentiated from induced pluripotent stem cells (iPSCs) harvested from a healthy donor into the striatum with QA-induced model of HD.</p> <p><bold>Materials and methods.</bold> The effects of neurotransplantation on reproduction of the conditioned passive avoidance reflex were studied in rats with the model of HD induced by injection of QA into the caudate nuclei of the striatum. In the study group (n=8), human neural progenitors (1×10<sup>6 </sup>per 10 µl of normal saline unilaterally, on the injured side) derived from iPSCs harvested from a healthy donor were injected into the caudate nuclei as the transplanted material; normal saline was injected in the control group. The conditioned passive avoidance responses were tested using the ShutАvoid 1.8.03 software on a Harvard apparatus (Panlab, Spain).</p> <p><bold>Results.</bold> When testing the reproduction of the passive avoidance responses, we found that injection of QA into the caudate nuclei of the rat brain reliably reduced the conditioned responses. Neurotransplantation of neural progenitors derived from iPSCs had a clear therapeutic effect and reinforced the passive avoidance reflex. During the entire testing period (7 days after exposure to the pain stimulus), the experimental animals either did not visit the dark compartment at all or visited it with a long latency period.</p> <p><bold>Conclusions.</bold> Experimental neurotransplantation using iPSC derivatives allowance to improve storage of trace memory in rats with QA-induced model of HD, which contributes to correction of cognitive impairments caused by administration of the neurotoxin.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Модель с введением хинолиновой кислоты (ХК) в стриатум крыс воспроизводит многие клинико-морфологические характеристики болезни Гентингтона (БГ). В силу фатального характера БГ актуальным является поиск эффективных методов ее лечения, одним из которых является создание нейропротекторной среды для замедления текущего дегенеративного процесса и/или замещении погибших нейронов. Это можно осуществить, в частности, посредством трансплантации клеток, обладающих способностью к нейрональной дифференцировке и интеграции в соответствующие структурно-функциональные церебральные сети.</p> <p><bold>Цель исследования</bold>. Оценка эффективности и безопасности трансплантации в стриатум крыс с ХК-индуцированной моделью БГ нейрональных предшественников, дифференцированных из индуцированных плюрипотентных стволовых клеток (ИПСК) здорового донора.</p> <p><bold>Материалы и методы.</bold> Исследованы эффекты нейротрансплантации на воспроизведение условного рефлекса пассивного избегания у крыс с моделью БГ, вызванной введением ХК в хвостатые ядра. В основной группе животных (n=8) в качестве трансплантируемого материала в хвостатые ядра вводили человеческие нейрональные предшественники (1×10<sup>6 </sup>в 10 мкл физиологического раствора унилатерально, на стороне повреждения), полученные из ИПСК здорового донора; в контрольной группе (n=8) – физиологический раствор. Тестирование условных реакций пассивного избегания проводили с помощью программы ShutАvoid 1.8.03 на установке фирмы Panlab Harvard Apparatus (Spain).</p> <p><bold>Результаты.</bold> При тестировании воспроизведения реакций пассивного избегания было обнаружено, что введение ХК в хвостатые ядра мозга крыс достоверно ослабляло условные реакции. Нейротрансплантация нейрональных предшественников, полученных из ИПСК, имела отчетливый терапевтический эффект и упрочила рефлекс пассивного избегания. На протяжении всего периода тестирования (7 суток после нанесения болевого воздействия) экспериментальные животные либо вовсе не переходили в темный отсек, либо переходили с большим латентным периодом.</p> <p><bold>Заключение.</bold> Нейротрансплантация с использованием производных ИПСК в эксперименте позволяет улучшить сохранение памятного следа у крыс с ХК-индуцированной моделью БГ, что способствует коррекции когнитивных нарушений, вызванных введением нейротоксина.</p></trans-abstract><kwd-group xml:lang="en"><kwd>uinolinic acid</kwd><kwd>Huntington’s disease</kwd><kwd>conditioned passive avoidance reflex, trace memory disturbance</kwd><kwd>neurotransplantation</kwd><kwd>neural progenitors</kwd><kwd>induced pluripotent stem cells</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хинолиновая кислота</kwd><kwd>болезнь Гентингтона</kwd><kwd>условный рефлекс пассивного избегания</kwd><kwd>нарушение памятного следа</kwd><kwd>нейротрансплантация, нейрональные предшественники, индуцированные плюрипотентные стволовые клетки</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993; 72: 971–983. PMID: 8458085</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ivanova-Smolenskaya I.A., Markova E.D., Illarioshkin S.N., Nikol’skaya N.N. Monogenic hereditary diseases of the central nervous system. In: Hereditary diseases of nervous system. Guidelines for doctors. Vel’tishcheva J.E., Temina P.A. (Eds.). Moscow: Meditsina. 1998: 9–104. (in Russ.)</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Estrada Sanchez AM, Mejia-Toiber J, Massieu L. Excitotoxic neuronal death and the pathogenesis of Huntington’s disease. Arch Med Res 2008;39:265–276. PMID: 18279698 DOI: 10.1016/j.arcmed.2007.11.011</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bachoud-Levi A.-C. Neural grafts in Huntington’s disease: Viability after 10 years. Lancet Neurol. 2009; 8: 979–981. PMID: 19833293 DOI: 10.1016/S1474-4422(09)70278-9</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Cicchetti F, Saporta S, Hauser RA et al. Neural transplants in patients with Huntington’s disease undergo disease-like neuronal degeneration. Proc. Natl. Acad. Sci. USA. 2009; 106: 12483–12488. PMID: 19620721 DOI: 10.1073/pnas.0904239106</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kerkis I., Haddad M, Valverde C., Glosman S. Neural and mesenchymal stem cells in animal models of Huntington’s disease: past experiences and future challenges. Stem Cell Research &amp; Therapy. 2015; 6: 232. PMID: 26667114 DOI: 10.1186/s13287-015-0248-1</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Maucksch C., Vazey E., Gordon R., Connor B. Stem cell-based therapy for Huntington’s disease. J. Cell. Biochem. 2013; 114: 754–763. PMID: 23097329 DOI: 10.1002/jcb.24432</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Reuter I, Tai YF, Pavese N et al. Long-term clinical and positron emission tomography out- come of fetal striatal transplantation in Huntington’s disease. J Neurol Neurosurg Psychiatry 2008; 79:948–951.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Nekrasov E.D., Lebedeva O.S., Vasina E.M. et al. [Platform for studying of Huntington's disease on the base of induced pluripotent stem cells]. Annals of Clinical and Experimental Neurology. 2012; 6(4): 30–35. (in Russ.)</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Fink K., Crane A. et al., Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington’s disease. Stem Cells Translational Medicine. 2014; 3: 620–631. PMID: 24657963 DOI: 10.5966/sctm.2013-0151</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Fink K., Rossignol J., Lu M. et al. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Cell Transplant. 2013 [Epub ahead of print]. PMID: 23879897 DOI: 10.3727/096368913X670958</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Peng J., Zeng X. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases. Stem Cell Res. Ther. 2011; 2: 32. PMID: 21861938 DOI: 10.1186/scrt73</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663–676. PMID: 16904174 DOI: 10.1016/j.cell.2006.07.024</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010; 465: 704–712. PMID: 20535199 DOI: 10.1038/nature09229</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Stavrovskaya A.V., Konorova I.L., Illarioshkin S.N. et al. [Technologies of nervous system diseases modeling]. In: Neurology of the 21st century: diagnostic, medical and research technologies. Piradov M.A., Illarioshkin S.N., Tanashyan M.M. (Eds). Мoscow: «АТМО». 2015; 3: 73–133. (in Russ.)</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Leavitt B.R., Raamsdonk J.M., Shehadeh J. et al. Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem 2006; 96: 1121-1129. PMID:16417581 DOI: 10.1111/j.1471-4159.2005.03605.x</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Paxinos G., Watson C. The Rat Brain in stereotaxic coordinates. Fourth Edition Academic Press 1998. - 456 p.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Miroshnichenko E.V., Stavrovskaya A.V., Shugalev N.P. et al. [Changes of an emotional condition of rats at representation of passive avoidance reactions after neurotensin administration into nucleus accumbens of rat brain]. Zhurnal vysshei nervnoi deyatelnosti im. I.P.Pavlova .2010; 60(6): 704-711. (in Russ.)</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Stavrovskaya A.V., Yamshikova N.G., Olshansky A.S. et al. [Neurotensin changes an after-action of a painful stress to behavior of rats with lesion of serotoninergic structures of substancia nigra]. Zhurnal vysshei nervnoi deyatelnosti im. I.P.Pavlova. 2013; 63(3): 384-394. (in Russ.)</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Shugalev N.P., Stavrovskaya A.V., Yamshikova N.G. et al. [Representation of of passive avoidance reactions after neurotensin administration into nucleus accumbens of rat brain against the background of Reserpine action]. Zhurnal vysshei nervnoi deyatelnosti im. I.P.Pavlova. 2012; 62(3): 357-363. (in Russ.)</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Roberts T.J., Price J., Williams S.C., Modo M. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington’s disease. Neuroscience. 2006;139:1187–1199. PMID: 16517087 DOI:10.1016/j.neuroscience.2006.01.025</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Kendall A., Hantraye P., Palfi S. Striatal tissue transplantation in non-human primates. Prog. Brain Res. 2000; 127: 381–404. PMID: 11142037 DOI:10.1016/S0079-6123(00)27018-0</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Shen L.H., Li Y., Chen J. et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience. 2006;137:393–9. PMID: 16298076 DOI: 10.1016/j.neuroscience.2005.08.092</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Shyu W.C., Lin S.Z., Chiang M.F. et al. Intracerebral peripheral blood stem cell (CD34z) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci. 2006;26:3444–53. PMID: 16571751, DOI: 10.1523/JNEUROSCI.5165-05.2006</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Nakao N., Nakayama T., Yahata T. et al. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol. 2010; 177(2): 547–54. PMID: 20558580 DOI:10.2353/ajpath.2010.091042</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Ribeiro C.A., Grando V., Dutra Filho C.S. et al. Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats. J Neurochem 2006; 99: 1531-1542. DOI:10.1111/j.1471-4159.2006.04199.x</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>McLin J.P., Thompson L.M., Steward O. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains. Eur J Neurosci 2006; 24: 3134-3140. DOI:10.1111/j.1460-9568.2006.05198.x</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Emerich D.F., Thanos C.G., Goddard M. et al. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol. Dis 2006; 23: 471-480. PMID: 16777422 DOI:10.1016/j.nbd.2006.04.014</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Kendall A.L., David F., Rayment G. et al. The influence of excitotoxic basal ganglia lesions on motor performance in the common marmoset. Brain 2000; 123 (Pt 7):1442-1458. PMID: 10869056 DOI:10.1093/brain/123.7.1442</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Becker S., Lim J. A computational model of prefrontal control in free recall: strategic memory use in the California Verbal Learning Task. J. Cogn. Neurosci. 2003; 15: 821–832. PMID: 14511535 DOI: 10.1162/089892903322370744</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Illarioshkin S.N. Huntington's disease as model for studying of neurodegenerative diseases. Byulleten natsional’ogo obshchestva po izucheniyu bolezni Parkinsona i rasstroystvam dvizheniy. 2016; 1: 3–11. (in Russ.)</mixed-citation></ref></ref-list></back></article>
